loading...| Preferred Name |
Meropenem |
|
| Synonyms |
1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4R-(3(3S*,5S*),4alpha,5beta,6beta(R*)))- |
|
| Definitions |
A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000077731 |
|
| altLabel |
1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4R-(3(3S*,5S*),4alpha,5beta,6beta(R*)))- SM-7338 Merrem SM7338 Penem 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid SM 7338 Ronem |
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
| cui |
C0286095 C2713389 C0066005 C0740029 C3489464 |
|
| DC |
1 |
|
| definition |
A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients. |
|
| DX |
20190101 |
|
| HN |
2019 (1989) |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
FV9J3JU8B1 0 |
|
| isa | ||
| LT |
TRD |
|
| Machine permutation |
2019; MEROPENEM was indexed under THIENAMYCINS 1989-2018 |
|
| Mapped from | ||
| MDA |
20180709 |
|
| MMR |
20180410 |
|
| MN |
D03.633.100.300.124.300.750 D02.065.589.099.124.300.750 |
|
| notation |
D000077731 |
|
| PA |
D000900 |
|
| prefLabel |
Meropenem |
|
| RR |
96036-03-2 (Meropenem) |
|
| TERMUI |
T195502 T195501 T000941291 T823929 T000940949 T754175 T195503 |
|
| TH |
NLM (2009) NLM (2012) USAN (19XX) INN (19XX) NLM (1989) FDA SRS (2015) |
|
| tui |
T109 T195 |
|
| subClassOf |